Back
Hexagon AB Vs. Viking Therapeutics Industry Stock Comparison
Sell
35
HXGBF
Hexagon AB
Last Price:
10.37
Seasonality Move:
2.68%
Buy
58
VKTX
Viking Therapeutics
Last Price:
61.63
Seasonality Move:
36.82%
Sell
35
Hexagon AB (HXGBF)
is a Sell
Is Hexagon AB a Buy, Sell or Hold?
- The current Hexagon AB [HXGBF] share price is $10.37. The Score for HXGBF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HXGBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $61.63. The Score for VKTX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HXGBF Stock Price Chart
What is Hexagon AB's stock price today?
-
The Hexagon AB share price today is $10.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HXGBF is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $61.63
The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
HXGBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 64.06 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.58 - 10.48) | Buy |
| Bollinger Bands (100): | (9.98 - 11.44) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.12 | Buy |
| Relative Strength Index (14 RSI): | 49.26 | Sell |
| Chaikin Money Flow: | -1176939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.9 - 66.32) | Sell |
| Bollinger Bands (100): | (52.14 - 66.8) | Buy |
HXGBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.85 | Buy |
| 20-day SMA: | 9.94 | Buy |
| 50-day SMA: | 10.09 | Buy |
| 200-day SMA: | 11.11 | Sell |
| 8-day EMA: | 10 | Buy |
| 20-day EMA: | 9.95 | Buy |
| 50-day EMA: | 10.19 | Buy |
| 200-day EMA: | 10.72 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.66 | Sell |
| 20-day SMA: | 61.87 | Sell |
| 50-day SMA: | 59.76 | Buy |
| 200-day SMA: | 53.91 | Buy |
| 8-day EMA: | 63.35 | Sell |
| 20-day EMA: | 62.66 | Sell |
| 50-day EMA: | 60.77 | Buy |
| 200-day EMA: | 52.02 | Buy |
Hexagon AB Earnings Growth & HXGBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Hexagon AB Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||